Safety and Effectiveness of Propagermanium in Focal Segmental Glomerulosclerosis Participants Receiving Irbesartan
Conditions
- Focal Segmental Glomerulosclerosis
Interventions
- DRUG: Propagermanium
- DRUG: Placebo
Sponsor
Dimerix Bioscience Pty Ltd
Collaborators